Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Resource Type
Article
Authors
McCormack, M ; Whitmarsh, K ; Allerton, R ; Gregory, D ; Symonds, P ; Hoskin, PJ ; Adusumalli, M ; Anand, A ; Wade, R ; Stewart, A ; Taylor, W ; Lutgens, LCHW ; Hollema, H ; Pras, E ; Snyers, A ; Westerveld, GH ; Jobsen, JJ ; Slot, A ; Mens, JM ; Stam, TC ; Van Triest, B ; Van der Steen-Banasik, EM ; De Winter, KAJ ; Quinn, MA ; Kolodziej, I ; Pyman, J ; Johnson, C ; Capp, A ; Fossati, R ; Colombo, A ; Carinelli, S ; Ferrero, A ; Artioli, G ; Davidson, C ; McLachlin, CM ; Ghatage, P ; Rittenberg, PVC ; Souhami, L ; Thomas, G ; Duvillard, P ; Berton-Rigaud, D ; Tubiana-Mathieu, N ; de Boer, Stephanie M ; Powell, Melanie E ; Mileshkin, Linda ; Katsaros, Dionyssios ; Bessette, Paul ; Haie-Meder, Christine ; Ottevanger, Petronella B ; Ledermann, Jonathan A ; Khaw, Pearly ; D'Amico, Romerai ; Fyles, Anthony ; Baron, Marie-Helene ; Jürgenliemk-Schulz, Ina M ; Kitchener, Henry C ; Nijman, Hans W ; Wilson, Godfrey ; Brooks, Susan ; Gribaudo, Sergio ; Provencher, Diane ; Hanzen, Chantal ; Kruitwagen, Roy F ; Smit, Vincent T H B M ; Singh, Naveena ; Do, Viet ; Lissoni, Andrea ; Nout, Remi A ; Feeney, Amanda ; Verhoeven-Adema, Karen W ; Putter, Hein ; Creutzberg, Carien L
Source
In The Lancet Oncology September 2019 20(9):1273-1285
Subject
Primary Research Articles
Language
ISSN
1470-2045